VMVittoria Maresca

Vittoria Maresca

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vittoria Maresca has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The α‐melanocyte‐stimulating hormone/melanocortin‐1 receptor interaction: A driver of pleiotropic effects beyond pigmentation

    by Cecilia Herraiz, Idoya Martínez‐Vicente, Vittoria Maresca

    Melanocortin‐1 Receptor (MC1R), when stimulated by alpha‐melanocyte‐stimulating hormone (α‐MSH), is a driver of eumelanogenesis. Brown/black eumelanin is an effective filter against ultraviolet radiation (UVR) and is a scavenger of free radicals. Several polymorphic variants of MC1R are frequent in red‐head people. These polymorphisms reduce the ability of MC1R to promote eumelanogenesis after its activation and spontaneous pheomelanogenesis take place. Since pheomelanin can act as an endogenous photosensitizer, people carrying MC1R polymorphisms are more susceptible to skin cancer. Here, we summarize current knowledge on the biology of MC1R beyond its ability to drive eumelanogenesis. We analyze its capacity to cope with oxidative insult and consequent DNA damage. We describe its ability to transduce through different pathways. We start from the canonical pathway, the cAMP/protein kinase A (PKA) pathway mainly involved in promoting eumelanogenesis, and protection from oxidative damage, and we then move on to describe more recent knowledge concerning ERK pathways, phosphoinositide 3‐kinase (PI3K) pathway/AKT, and α‐MSH/Peroxisome proliferators activated receptor‐γ (PPAR‐γ) connection. We describe MC1R polymorphic variants associated with melanoma risk which represent an open window of clinical relevance.


  • The PI3K pathway induced by αMSH exerts a negative feedback on melanogenesis and contributes to the release of pigment

    by Sarah Mosca, Giorgia Cardinali, Enrica Flori, Stefania Briganti, Irene Bottillo, Anna Maria Mileo, Vittoria Maresca

    The Melanocortin‐1 receptor (MC1R) belongs to the family of the G protein Coupled Receptor (GPCR). Activated GPCRs can promote the phosphoinositide 3‐kinase (PI3K) pathway. Few studies deal with the role of the PI3K‐pathway activation in response to αMSH. On B16‐F10 cell line, we investigated the αMSH‐dependent modulation of pAKT/AKT, as a key element of the PI3K pathway after rapid and prolonged stimulation. We demonstrated that αMSH triggers a rapid modulation of AKT which culminates in an increase in its phosphorylation. We highlighted a comparable up‐regulation of pAKT after exposure to αMSH on primary cultures of normal human melanocytes (NHMs) expressing a wild type MC1R. On B16‐F10 cells, NHMs and an ex‐vivo model of human skin biopsies, we explored the influence of PI3K/AKT signaling triggered by αMSH, focusing on the control of melanogenesis and pigment release. We showed that the αMSH‐dependent PI3K/AKT pathway exerts a negative feedback on melanogenesis and promotes the extracellular release of pigment. We strengthened the role of the PI3K/AKT pathway triggered by αMSH in preserving redox equilibrium and genome integrity, highlighting its role in affecting cell survival.


  • Open Access

    The α-melanocyte stimulating hormone/peroxisome proliferator activated receptor-γ pathway down-regulates proliferation in melanoma cell lines

    by Enrica Flori, Eleonora Rosati, Giorgia Cardinali, Daniela Kovacs, Barbara Bellei, Mauro Picardo, Vittoria Maresca

    The α-Melanocyte Stimulating Hormone (αMSH)/Melanocortin-1 receptor (MC1R) interaction promotes melanogenesis through the cAMP/PKA pathway. The direct induction of this pathway by Forskolin (FSK) is also known to enhance melanocyte proliferation. αMSH acts as a mitogenic agent in melanocytes and its effect on proliferation of melanoma cells is less known. We previously identified the αMSH/Peroxisome Proliferator Activated Receptor (PPARγ) pathway as a new pathway on the B16-F10 mouse melanoma cell line. αMSH induced the translocation of PPARγ into the nucleus as an active transcription factor. This effect was independent of the cAMP/PKA pathway and was mediated by the activation of the PI(4,5)P2/PLC pathway, a pathway which we have described to be triggered by the αMSH-dependent MC1R stimulation. Moreover, in the same study, preliminary experiments showed that mouse melanoma cells responded to αMSH by reducing proliferation and that PPARγ was involved in this effect. Due to its key role in the control of cell proliferation, PPARγ agonists are used in therapeutic models for different forms of cancer, including melanoma. The purpose of this study was: (a) to confirm the different proliferative behavior in response to αMSH in healthy and in melanoma condition; (b) to verify whether the cAMP/PKA pathway and the PLC/PPARγ pathway could exert an antagonistic function in the control of proliferation; (c) to deepen the knowledge of the molecular basis responsible for the down-proliferative response of melanoma cells after exposure to αMSH. We employed B16-F10 cell line, a human melanoma cell line (Mel 13) and two primary cultures of human melanocytes (NHM 1 and NHM 2, respectively), all expressing a wild type MC1R and responding to the αMSH in terms of pigmentation. We evaluated cell proliferation through: a) cell counting, b) cell cycle analysis c) protein expression of proliferation modulators (p27, p21, cyclin D1 and cyclin E). The αMSH acted as a mitogenic agent in primary cultures of human melanocytes, whereas it determined a slow down of proliferation in melanoma cell lines. FSK, as an inducer of the cAMP/PKA pathway, reproduced the αMSH mediated effect on proliferation in NHMs but it did not mimic the αMSH effect on proliferation in B16-F10 and Mel 13 melanoma cell lines. Meanwhile, 3 M3-FBS (3 M3), as an inducer of PI(4,5)P2/PLC pathway, reproduced the αMSH proliferative effect. Further experiments, treating melanoma cell lines with αMSH in the presence/absence of GW9662, as an inhibitor of PPARγ, confirmed the key role of this transcription factor in decreasing cell proliferation in response to the hormone exposure. In both melanoma cell lines, αMSH determined the reduction of proliferation through the PI(4,5)P2/PLC pathway, employing PPARγ as an effector element. These evidence could offer perspectives for new therapeutic approaches for melanoma.


  • Open Access

    Skin phototype: a new perspective

    by Vittoria Maresca, Enrica Flori, Mauro Picardo

    Summary: Cutaneous phototype is considered mainly related to cutaneous pigmentation and to the eumelanin/pheomelanin ratio, which is mostly genetically determined by the melanocortin 1 receptor (MC1R) polymorphisms. However, data in literature indicate that, in addition to stimulation of eumelanin synthesis, the MC1R signalling activates antioxidant, DNA repair and survival pathways. New emerging aspects regarding photoprotection and skin phototypes are going beyond those features connected to the melanin content in the skin. Important new findings link the MC1R to nuclear receptors activation, shedding light on new extra‐melanogenic effects dependent on the α‐melanocyte‐stimulating hormone (α‐MSH) activity and new ways through which such functions are modulated. These evidences indicate that several factors including melanin play a part in defining the basis for individual sun sensitivity, suggesting that the cutaneous phototype represents a ‘biochemical fingerprint’.


  • Linking αMSH with PPARγ in B16‐F10 melanoma

    by Vittoria Maresca, Enrica Flori, Emanuela Camera, Barbara Bellei, Nicaela Aspite, Matteo Ludovici, Caterina Catricalà, Giorgia Cardinali, Mauro Picardo

    Summary: We have discovered a new α‐melanocyte stimulating hormone (α‐MSH)/peroxisome proliferator activated receptor‐γ (PPAR‐γ) connection in B16‐F10 cells. Both PPAR‐γ up‐regulation and its induction as an active transcription factor were observed in response to α‐MSH. The α‐MSH/PPAR‐γ connection influenced both pigmentation and proliferation. The forskolin‐stimulated cAMP/PKA pathway was not able to induce either PPAR‐γ translocation into the nucleus or PPAR‐γ transcriptional activity. As the melanocortin‐1 receptor, the specific receptor for the α‐MSH, is a G‐protein coupled receptor, we wondered whether the phosphatidylinositol [PI(4,5)P2/PLCβ] signal pathway was involved in mediating the α‐MSH‐dependent PPAR‐γ activation. Employing inhibitors of PI(4,5)P2/PLCβ pathway, the results of our experiments suggested that this pathway was promoted by α‐MSH and that α‐MSH played a role in mediating PPAR‐γ activation. We have demonstrated, for the first time, that α‐MSH induces the PI(4,5)P2/PLCβ pathway, through analysis of the basic steps of the pathway. The α‐MSH effect on PPAR‐γ was independent of animal species and was not correlated with the physio‐pathological status.


  • The Eumelanin Intermediate 5,6-Dihydroxyindole-2-Carboxylic Acid Is a Messenger in the Cross-Talk among Epidermal Cells

    by Daniela Kovacs, Enrica Flori, Vittoria Maresca, Monica Ottaviani, Nicaela Aspite, Maria Lucia Dell'ANna, Lucia Panzella, Alessandra Napolitano, Mauro Picardo, Marco D'ISchia


  • Open Access

    p38 Regulates Pigmentation via Proteasomal Degradation of Tyrosinase

    by Barbara Bellei, Vittoria Maresca, Enrica Flori, Angela Pitisci, Lionel Larue, Mauro Picardo


  • Open Access

    MC1R stimulation by α-MSH induces catalase and promotes its re-distribution to the cell periphery and dendrites

    by Vittoria Maresca, Enrica Flori, Barbara Bellei, Nicaela Aspite, Daniela Kovacs, Mauro Picardo

    We demonstrated a direct correlation between melanogenic and catalase activities on in vitro and ex vivo models. Here, we investigated whether the stimulation of Melanocortin‐1 Receptor (MC1R) could influence catalase expression, activity and cellular localization. For this purpose, we treated B16‐F0 melanoma cells with α‐Melanocyte Stimulating Hormone (α‐MSH) and we showed a rapid induction of catalase through a cAMP/PKA‐dependent, microphthalmia‐associated transcription factor (MITF) independent mechanism, acting at post‐transcriptional level. Moreover, α‐MSH promoted a partial re‐distribution of catalase to the cell periphery and dendrites. This work strengthens the correlation between melanogenesis and anti‐oxidants, demonstrating the induction of catalase in response to a melanogenic stimulation, such as α‐MSH‐dependent MC1R activation. Moreover, this study highlights catalase regulatory mechanisms poorly known, and attributes to α‐MSH a protective role in defending melanocytes, and possibly keratinocytes, not only on the basis of its pigmentary action, but also for its capacity to stimulate a quick anti‐oxidant defence.


  • Acidic catalase in human skin in vivo: a new marker of permanent damage

    by Vittoria Maresca, Enrica Flori, Claudia Fabbri, Stefania Briganti, Giustino Mariani, Caterina Catricalà, Mauro Picardo

    Malignant melanoma incidence is increasing rapidly in Western countries. Its prevention requires a deep knowledge of the biological basis of the neoplasm leading to the identification of new biological risk markers. In in-vitro and ex-vivo models we demonstrated that catalase was modified not only in its activity but also in its charge properties after ultraviolet A irradiation through pheomelanin. Here we focus on the electrophoretic behaviour of catalase in the human skin in vivo, in association with cutaneous phototype. Zymographic analysis of the enzyme on skin biopsies from Caucasian population (phototype I–IV), collected from the trunk in autumn–winter, to exclude possible influences of an acute photoexposure, evidenced a protein doublet, representing the coexistence of two active isoforms of catalase with different charge properties. In the skin from low-phototype subjects, the percent contribution of the more acidic component of the doublet was prevalent, inversely correlated with total melanin concentration in hair, and associated with a high number of melanocytic nevi. In summary, this study shows for the first time the existence of an acidic catalase in association with clinically defined risk characteristics in low phototype skin in vivo, contributing to the knowledge of a new biochemical marker of cutaneous photosusceptibility.


  • GSK3β inhibition promotes melanogenesis in mouse B16 melanoma cells and normal human melanocytes

    by Barbara Bellei, Enrica Flori, Enzo Izzo, Vittoria Maresca, Mauro Picardo